Zura Bio Future Growth
Future criteria checks 0/6
Zura Bio's earnings are forecast to decline at 28.4% per annum while its annual revenue is expected to grow at 71.4% per year. EPS is expected to decline by 19.2% per annum.
Key information
-28.4%
Earnings growth rate
-19.2%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 71.4% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 18 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4 | -86 | -65 | -87 | 7 |
| 12/31/2025 | N/A | -65 | -47 | -59 | 8 |
| 12/31/2024 | N/A | -50 | -30 | -20 | 8 |
| 9/30/2024 | N/A | -43 | -26 | -21 | N/A |
| 6/30/2024 | N/A | -28 | -25 | -18 | N/A |
| 3/31/2024 | N/A | -60 | -30 | -17 | N/A |
| 12/31/2023 | N/A | -69 | -23 | -15 | N/A |
| 9/30/2023 | N/A | -88 | -27 | -11 | N/A |
| 6/30/2023 | N/A | -81 | -23 | -9 | N/A |
| 3/31/2023 | N/A | -41 | -15 | -4 | N/A |
| 12/31/2022 | N/A | -35 | -14 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 94E is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 94E is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 94E is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 94E is forecast to have no revenue next year.
High Growth Revenue: 94E is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 94E's Return on Equity is forecast to be high in 3 years time